Rangeley Capital »

Drugs Made In Amer Acq Ii shares owned by Rangeley Capital

Quarter-by-quarter ownership of Drugs Made In Amer Acq Ii (DMIIU) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Drugs Made In Amer Acq Ii

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acq Ii held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acq Ii by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $326k 33k 10.02

More positions owned by Rangeley Capital

Warner Bros Discovery Com Ser A Call Option (WBD)
Golden Entmt (GDEN)
Calumet (CLMT)
Prothena Corp SHS (PRTA)
Yext (YEXT)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Avidity Biosciences Ord (RNA)
Repare Therapeutics Ord
Kennedy-Wilson Holdings (KW)
Seaport Entmt Group Common Stock (SEG)
Delek Us Holdings (DK)
Berto Acquisition Corp Ord Shs (TACO)
Grindr (GRND)
Plymouth Indl Reit

View all positions for Rangeley Capital

Top funds holding Drugs Made In Amer Acq Ii

MMCAP International Inc. SPC
Magnetar Financial
Millennium Management
Healthcare Of Ontario Pension Plan Trust Fund
LMR Partners
Tenor Capital Management
Polar Securities
CNH Partners
D. E. Shaw & Co
Two Sigma Investments
Moore Capital Management
Radcliffe Capital Management
Heights Capital Management
Westchester Capital Management
TIG Advisors

View all funds holding Drugs Made In Amer Acq Ii